DoiT — the cloud‑cost intelligence firm behind Cloud Intelligence™ — has rolled out Attribute, a new platform that promises real‑time AI spend attribution down to the token, model request and GPU cycle. The announcement, made on July 7, 2026, signals a shift toward finer‑grained cost visibility for enterprises wrestling with soaring generative‑AI budgets. What Attribute does Attribute installs a lightweight eBPF sensor…
What DXC Unveiled The Bengaluru center consolidates several purpose‑built environments: Customer Experience Zones, Fluid Collaboration Hubs, Ideation Studios, Co‑Creation Labs, and Partner Experience Zones. At its core lies an AI Hub equipped with a Cyber Range, Forensics Labs, a Security Operations Center, and a Network Operations Center. The layout enables clients to move from concept…
Insilico Medicine has moved its AI‑designed TNIK inhibitor, Rentosertib, into a Phase III clinical trial, marking a rare end‑to‑end showcase of generative‑AI drug discovery for idiopathic pulmonary fibrosis (IPF). Insilico Medicine, the Hong Kong‑listed biotech that builds its pipeline on generative‑AI platforms such as Pharma.AI, announced on July 7 that the once‑daily oral molecule Rentosertib will enter…
CyberProof Inc., a UST company, announced today the launch of its CyberProof Agentic MXDR service—a co‑managed security offering that fuses generative AI agents with human analysts to deliver end‑to‑end threat detection, response, and exposure management for large enterprises and mid‑market organizations. What the Service Is CyberProof Agentic MXDR is positioned as a 24/7 co‑managed managed detection and response (MXDR) platform…
Duck Creek Technologies announced Monday that it has acquired Send Technology Solutions Ltd, creating an AI underwriting platform that merges Duck Creek’s intelligent core with AI‑native orchestration engine to reshape commercial, specialty and London market insurance underwriting. What the deal entails The Boston‑based Duck Creek, a long‑standing provider of core insurance software, disclosed a cash‑plus‑stock…
